Mast Cell Activation Syndrome

(asked on 23rd February 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will include Mast Cell Activation Syndrome (MCAS) in the 100K genome project and establish links to the MCAS Research Centre at the University of Bonn Institute of Genetics.


Answered by
Jackie Doyle-Price Portrait
Jackie Doyle-Price
This question was answered on 5th March 2018

Mast Cell Activation Syndrome (MCAS) does not currently have a specific disease category within the 100,000 Genomes Project but patients with MCAS in the context of other medical disorders or congenital malformations suggestive of a genetic cause are eligible. In addition, a proposal for inclusion of familial MCAS in the project is currently under peer review and will be considered by the Genomics England Science Advisory Committee at their next meeting.

Genomics England will seek to establish links between the relevant Genomics England Clinical Interpretation Partnership (GeCIP) domains and the MCAS Research Centre at the University Of Bonn Institute Of Genetics.

More about GeCIP can be found here:

https://www.genomicsengland.co.uk/about-gecip/

Reticulating Splines